Caroff, Stanley N. http://orcid.org/0000-0003-2840-4763
Mu, Fan
Ayyagari, Rajeev
Schilling, Traci
Abler, Victor
Carroll, Benjamin
Funding for this research was provided by:
Teva Pharmaceutical Industries (N/A)
Article History
Received: 30 September 2019
Accepted: 19 June 2020
First Online: 11 July 2020
Ethics approval and consent to participate
: The database complies with the privacy rules of the Health Insurance Portability and Accountability Act. This retrospective database analysis was granted an exemption by the New England Independent Review Board on August 31, 2017. As all pre-existing data within the database were anonymized, no informed consent was required.
: Not applicable.
: <b>SNC</b>: Consultant for Teva Pharmaceuticals, Neurocrine Biosciences, Inc., Osmotica Pharmaceuticals, and DisperSol Technologies; received a research grant from Neurocrine Biosciences, Inc.<b>FM</b>: Employee of Analysis Group, Inc.<b>RA</b>: Employee of Analysis Group, Inc.<b>TS</b>: Employee of Teva Branded Pharmaceutical Products R&D, Inc.<b>VA</b>: Former employee of Teva Pharmaceuticals.<b>BC</b>: Employee of Teva Branded Pharmaceutical Products R&D, Inc.